{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:26:42Z","timestamp":1789583202688,"version":"build-2803163510"},"publisher-location":"Chichester, UK","reference-count":76,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003906.pub3","type":"reference-entry","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T18:02:15Z","timestamp":1346781735000},"source":"Crossref","is-referenced-by-count":20,"title":["Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy"],"prefix":"10.1002","author":[{"given":"Man Mohan","family":"Mehndiratta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard AC","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD003906.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","article-title":"Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"314","author":"Dyck","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003906.pub3-BIB2|cit2","first-page":"197","article-title":"The Mayo Clinic Experience with plasma exchange in chronic inflammatory-demyelinating polyneuropathy (CIDP)","volume":"106","author":"Dyck","year":"1982","journal-title":"Progress in Clinical and Biological Research"},{"issue":"2","key":"10.1002\/14651858.CD003906.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1097-4598(200002)23:2<206::AID-MUS10>3.0.CO;2-K","article-title":"Impact of plasma exchange on indices of demyelination in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"23","author":"Ashworth","year":"2000","journal-title":"Muscle and Nerve"},{"issue":"Pt 4","key":"10.1002\/14651858.CD003906.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","article-title":"Plasma-exchange therapy in chronic inflammatory demyelinating polyradiculoneuropathy. A double-blind, sham-controlled, crossover study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"issue":"12","key":"10.1002\/14651858.CD003906.pub3-BIB5|cit5","first-page":"1336","article-title":"Treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)","volume":"36","author":"Baba","year":"1996","journal-title":"Rinsho Shinkeigaku - Clinical Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003906.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.410360607","article-title":"A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"36","author":"Dyck","year":"1994","journal-title":"Annals of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD003906.pub3-BIB7|cit7","first-page":"719","article-title":"Double filtration plasmapheresis (DFPP) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)","volume":"38","author":"Kumazawa","year":"1998","journal-title":"Rinsho Shinkeigaku - Clinical Neurology"},{"issue":"8","key":"10.1002\/14651858.CD003906.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2169\/naika.91.2443","article-title":"Clinical guideline review: Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"91","author":"Mori","year":"2002","journal-title":"Journal of Japanese Society of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.transci.2005.07.010","article-title":"A pilot study to compare the use of the Excorim staphylococcal protein immunoadsorption system and IVIG in Chronic Inflammatory Demyelinating Polyneuropathy","volume":"33","author":"Zinman","year":"2005","journal-title":"Transfusion and Apheresis Science"},{"issue":"1","key":"10.1002\/14651858.CD003906.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00002480-198609000-00020","article-title":"Treatment of chronic inflammatory demyelinating polyradiculoneuropathy by plasma filtration","volume":"32","author":"Abe","year":"1986","journal-title":"ASAIO Transactions"},{"issue":"5","key":"10.1002\/14651858.CD003906.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"41","year":"1991","journal-title":"Neurology"},{"issue":"8","key":"10.1002\/14651858.CD003906.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: Clinical characteristics, course, and recommendations for diagnostic criteria","volume":"46","author":"Barohn","year":"1989","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD003906.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/mus.21277","article-title":"Current treatments of chronic immune-mediated demyelinating polyneuropathies","volume":"39","author":"Brannagan III","year":"2009","journal-title":"Muscle and Nerve"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB14|cit14","first-page":"190","article-title":"Long term treatment of chronic inflammatory demyelinating polyradiculoneuropathy, combination of corticosteroids, plasma exchange and intravenous immunoglobulin","volume":"39","author":"Briellmann","year":"1998","journal-title":"European Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003906.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0895-4356(92)90187-R","article-title":"Prognosis in long-term immunosuppressive treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathy","volume":"45","author":"Bromberg","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD003906.pub3-BIB16|cit16","first-page":"493","article-title":"Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin","volume":"88","author":"Choudhary","year":"1995","journal-title":"QJM: monthly journal of the Association of Physicians"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","article-title":"Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"76","author":"Cortese","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003906.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.2920090102","article-title":"Complications of therapeutic plasma exchange: a recent assessment","volume":"9","author":"Couriel","year":"1994","journal-title":"Journal of Clinical Apheresis"},{"issue":"1-2","key":"10.1002\/14651858.CD003906.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0165-5728(98)00266-5","article-title":"Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy","volume":"95","author":"Luca","year":"1999","journal-title":"Journal of Neuroimmunology"},{"issue":"2","key":"10.1002\/14651858.CD003906.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.880070209","article-title":"Peripheral neuropathy in osteosclerotic myeloma: clinical and electrodiagnostic improvement with chemotherapy","volume":"7","author":"Donofrio","year":"1984","journal-title":"Muscle & Nerve"},{"issue":"11","key":"10.1002\/14651858.CD003906.pub3-BIB21|cit21","first-page":"621","article-title":"Chronic inflammatory polyradiculoneuropathy","volume":"50","author":"Dyck","year":"1975","journal-title":"Mayo Clinic Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD003906.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.410080608","article-title":"Human diabetic endoneurial sorbitol, fructose and myo-inositol related to sural nerve morphometry","volume":"8","author":"Dyck","year":"1980","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003906.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410110205","article-title":"Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment","volume":"11","author":"Dyck","year":"1982","journal-title":"Annals of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD003906.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.35.8.1173","article-title":"Combined azathioprine and prednisone in chronic inflammatory demyelinating polyneuropathy","volume":"35","author":"Dyck","year":"1985","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003906.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1468-1331.2006.01278.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society","volume":"13","author":"Hughes","year":"2006","journal-title":"European Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision","volume":"17","author":"Bergh","year":"2010","journal-title":"European Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003906.pub3-BIB27|cit27","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001797.pub2","article-title":"Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Eftimov","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003906.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00315684","article-title":"Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin","volume":"238","author":"Fredman","year":"1991","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB29|cit29","first-page":"129","article-title":"Plasma exchange treatment in chronic polyneuritis of the Guillain-Barr\u00e9 type. Experiences with 9 personal cases","volume":"57","author":"Gibbels","year":"1986","journal-title":"Nervenarzt"},{"issue":"2","key":"10.1002\/14651858.CD003906.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.48.2.321","article-title":"Chronic inflammatory demyelinating polyneuropathy: Clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy","volume":"48","author":"Gorson","year":"1997","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003906.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-510X(81)90135-0","article-title":"The treatment of chronic relapsing and chronic progressive idiopathic inflammatory polyneuropathy by plasma exchange","volume":"52","author":"Gross","year":"1981","journal-title":"Journal of the Neurological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD003906.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/jnnp.72.5.644","article-title":"Immunoadsorption inferior to plasma exchange in a patient with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"72","author":"Hadden","year":"2002","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003906.pub3-BIB33|cit33","first-page":"328","article-title":"Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies","volume":"152","author":"Hahn","year":"1996","journal-title":"Revue Neurologique (Paris)"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB34|cit34","first-page":"208","article-title":"Steroid therapy and plasmapheresis in chronic inflammatory demyelinating polyradiculoneuropathy: a long-term follow-up study","volume":"38","author":"Hanaoka","year":"1998","journal-title":"Rinsho Shinkeigaku"},{"issue":"1","key":"10.1002\/14651858.CD003906.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(84)90136-9","article-title":"Chronic inflammatory polyneuropathy. Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulin G","volume":"66","author":"Heininger","year":"1984","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD003906.pub3-BIB36|cit36","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.0.1 Chichester (UK) John Wiley & Sons"},{"key":"10.1002\/14651858.CD003906.pub3-BIB37|cit37","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD003906.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-510X(92)90217-9","article-title":"Antibodies to acidic glycolipids in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"107","author":"Ilyas","year":"1992","journal-title":"Journal of the Neurological Sciences"},{"issue":"7","key":"10.1002\/14651858.CD003906.pub3-BIB39|cit39","first-page":"930","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy of acute onset: relapse after temporary improvement by plasma exchange and longstanding remission by corticosteroid therapy","volume":"29","author":"Iwatsubo","year":"1989","journal-title":"Rinsho Shinkeigaku"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1212\/WNL.35.3.312","article-title":"Chronic progressive multiple sclerosis: Double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs","volume":"35","author":"Khatri","year":"1985","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jca.1024","article-title":"Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures","volume":"16","author":"Kiprov","year":"2001","journal-title":"Journal of Clinical Apheresis"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.82.3.905","article-title":"Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation","volume":"82","author":"Koski","year":"1985","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1002\/14651858.CD003906.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2169\/internalmedicine.34.537","article-title":"Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy; different beneficial effects and their correlation to the clinical features","volume":"34","author":"Kumazawa","year":"1995","journal-title":"Internal Medicine"},{"issue":"13","key":"10.1002\/14651858.CD003906.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMra041347","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"352","author":"K\u00f6ller","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003906.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/WCO.0b013e32830b0f61","article-title":"Plasma exchange in immune-mediated neuropathies","volume":"21","author":"Lehmann","year":"2008","journal-title":"Current Opinion in Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD003906.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jneuroim.2010.09.015","article-title":"Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies","volume":"231","author":"Lehmann","year":"2011","journal-title":"Journal of Neuroimmunology"},{"issue":"8136","key":"10.1002\/14651858.CD003906.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0140-6736(79)90276-9","article-title":"Treating chronic relapsing Guillain-Barr\u00e9 syndrome by plasma exchange","volume":"2","author":"Levy","year":"1979","journal-title":"Lancet"},{"issue":"8145","key":"10.1002\/14651858.CD003906.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(79)90665-2","article-title":"Treatment of chronic relapsing Guillain-Barr\u00e9 syndrome by plasma exchange","volume":"2","author":"Levy","year":"1979","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD003906.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.32.9.958","article-title":"Multifocal demyelinating neuropathy with persistent conduction block","volume":"32","author":"Lewis","year":"1982","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003906.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM198108063050613","article-title":"Plasma infusion and plasma exchange in chronic idiopathic polyneuropathy","volume":"305","author":"Maas","year":"1981","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD003906.pub3-BIB51|cit51","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003280.pub3","article-title":"Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Mahdi-Rogers","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Pt 6","key":"10.1002\/14651858.CD003906.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/brain\/110.6.1617","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases","volume":"110","author":"McCombe","year":"1987","journal-title":"Brain"},{"issue":"1","key":"10.1002\/14651858.CD003906.pub3-BIB53|cit53","article-title":"Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Mehndiratta","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1-2","key":"10.1002\/14651858.CD003906.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(01)00266-1","article-title":"Multifocal motor neuropathy","volume":"115","author":"Nobile-Orazio","year":"2001","journal-title":"Journal of Neuroimmunology"},{"issue":"8","key":"10.1002\/14651858.CD003906.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.55.8.677","article-title":"Chronic sensory demyelinating neuropathy: chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy","volume":"55","author":"Oh","year":"1992","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003906.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mus.880110203","article-title":"Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease","volume":"11","author":"Parry","year":"1988","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.1002\/14651858.CD003906.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0022-510X(83)90222-8","article-title":"Prediction of response to plasma exchange in chronic relapsing polyneuropathy. A clinico-pathological correlation","volume":"58","author":"Pollard","year":"1983","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/mus.880100304","article-title":"A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies","volume":"10","author":"Pollard","year":"1987","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1002\/14651858.CD003906.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0022-510X(76)90213-6","article-title":"Chronic relapsing polyneuritis","volume":"27","author":"Prineas","year":"1976","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.410060313","article-title":"Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange","volume":"6","author":"Server","year":"1979","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD003906.pub3-BIB62|cit62","first-page":"853","article-title":"Plasmapheresis in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"38","author":"Tanaka","year":"1998","journal-title":"Rinsho Shinkeigaku"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/92.3.589","article-title":"Recurrent and chronic relapsing Guillain-Barr\u00e9 polyneuritis","volume":"92","author":"Thomas","year":"1969","journal-title":"Brain"},{"issue":"6","key":"10.1002\/14651858.CD003906.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mus.880050610","article-title":"Plasma exchange in chronic inflammatory polyneuropathy: evidence suggestive of a pathogenic humoral factor","volume":"5","author":"Toyka","year":"1982","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1002\/14651858.CD003906.pub3-BIB65|cit65","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003217.pub4","article-title":"Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy","author":"Umapathi","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003906.pub3-BIB66|cit66","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1474-4422(10)70041-7","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition","volume":"9","author":"Vallat","year":"2010","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB67|cit67","first-page":"147","article-title":"Intravenous immunoglobulin (IVIG) in the treatment of chronic demyelinating polyradiculoneuropathy","volume":"101","author":"Bergh","year":"2001","journal-title":"Acta Neurologica Belgica"},{"issue":"11","key":"10.1002\/14651858.CD003906.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1212\/WNL.37.11.1798","article-title":"Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy","volume":"37","author":"Doorn","year":"1987","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003906.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1085-9489.2005.0010203.x","article-title":"Treatment of Guillain-Barr\u00e9 syndrome and CIDP","volume":"10","author":"Doorn","year":"2005","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"1","key":"10.1002\/14651858.CD003906.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1445-5994.1982.tb02434.x","article-title":"Specificity of plasmapheresis in the treatment of chronic relapsing polyneuropathy","volume":"12","author":"Nunen","year":"1982","journal-title":"Australian and New Zealand Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003906.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"Swieten","year":"1988","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD003906.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1212\/WNL.62.1.155","article-title":"Rapid resolution of quadriplegic CIDP by combined plasmapheresis and IVIg","volume":"2","author":"Walk","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003906.pub3-BIB73|cit73","unstructured":"International Classification of Impairment World Health Organization 1980"},{"key":"10.1002\/14651858.CD003906.pub3-BIB74|cit74","unstructured":"ICIDH-2: International classification of Impairments, Activities, and Participation World Health Organization 1997"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.1129","article-title":"P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Yan","year":"2001","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003906.pub3-BIB76|cit76","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003906.pub2","article-title":"Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Mehndiratta","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003906.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T00:00:00Z","timestamp":1440460800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003906.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:27:27Z","timestamp":1628530047000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003906.pub3"}},"subtitle":[],"editor":[{"given":"Man Mohan","family":"Mehndiratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":76,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003906.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717958482.793465027","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2012,9,12]]}}}